Amiodarone after myocardial infarction: EMIAT and CAMIAT trials

Comment

R M Norris. Lancet. 1997.

. 1997 Jun 14;349(9067):1767.

doi: 10.1016/s0140-6736(97)26024-1.

No abstract available

Comment on

Dead is dead--artificial definitions are no substitute.
Gottlieb SS. Gottlieb SS. Lancet. 1997 Mar 8;349(9053):662-3. doi: 10.1016/S0140-6736(97)22010-6. Lancet. 1997. PMID: 9078192 No abstract available.
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P. Julian DG, et al. Lancet. 1997 Mar 8;349(9053):667-74. doi: 10.1016/s0140-6736(96)09145-3. Lancet. 1997. PMID: 9078197 Clinical Trial.
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Cairns JA, Connolly SJ, Roberts R, Gent M. Cairns JA, et al. Lancet. 1997 Mar 8;349(9053):675-82. doi: 10.1016/s0140-6736(96)08171-8. Lancet. 1997. PMID: 9078198 Clinical Trial.